home · filing · 0001193125-24-041440
8-K
filed February 21, 2024, 6:59 PM ET
ticker NGNE
CIK 0001404644
leadership
confidence high
sentiment neutral
materiality 0.15
Neurogene appoints Donna Cochener as SVP and General Counsel
Neurogene Inc.
Donna Cochener appointed SVP, General Counsel effective February 15, 2024.
Base salary set at $370,000 annually; eligible for annual bonus up to 35% of salary.
Received option grant for 40,000 shares; 25% vests at one year, rest monthly over 36 months.
Prior consulting agreement terminated upon hire; no written employment agreement.
Executive movements
Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements .
Effective 2024-02-15
Filed February 21, 2024, 6:59 PM ET
On February 15, 2024, Neurogene Inc. (the “Company”) appointed Donna Cochener as Senior Vice President, General Counsel.
Key facts
Extracted from this filing and checked against the source text.
Executive change
SEC 8-K Item 5.02
confidence 1.0
Donna Cochener was appointed as Senior Vice President, General Counsel at Neurogene Inc..
Action appointed
Role Senior Vice President, General Counsel
Exact text from the filing
On February 15, 2024, Neurogene Inc. (the “Company”) appointed Donna Cochener as Senior Vice President, General Counsel.
View on SEC.gov
Source: SEC EDGAR
accession 0001193125-24-041440
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.